You can buy Photalaz at the lowest price in the online pharmacy Nextgen.ooo . Talazoparib is a poly-ADP-ribose polymerase inhibitor used to treat locally advanced or metastatic breast cancer with a BRCA mutation and metastatic castration-resistant prostate cancer with a mutation in the HRR genes. Talazoparib was approved by the FDA for use in BRCA germline-mutated, HER2-negative, locally advanced or metastatic breast cancer on October 16, 2018.
 
Talazoparib received approval based on results from the EMBRACA trial, in which talazoparib resulted in a median progression-free survival of 8.6 months compared to chemotherapy of the physician's choice, which resulted in a progression-free survival of 5.6 months.
 
Talazoparib is also indicated in combination with enzalutamide for the treatment of adult patients with HRR-mutated metastatic castration-resistant prostate cancer.